NIH-funded research NIH-funded research

Functional Connectivity-Guided TMS for Alcohol Use Disorder

Official title: Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Funded at Icahn School of Medicine at Mount Sinai · NIH-11601597 · Data updated 2026-11-12

A new approach uses targeted brain stimulation to help people with alcohol use disorder stay abstinent longer by focusing treatment on specific brain circuits.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00AA031508-03
Project IDNIH-11601597 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder who have experienced relapse or poor response to standard treatments and are seeking non-invasive brain-based therapy.

Less likely to help

Individuals without AUD or those who cannot undergo transcranial magnetic stimulation may not benefit from this approach.

What this research studies

This project aims to apply a brain-stimulation method called TMS, guided by brain connectivity, to strengthen neural circuits involved in craving and relapse in people with alcohol use disorder. By targeting the prefrontal cortex and its connected striatal regions, the study seeks to reduce reactivity to alcohol cues and improve treatment adherence. The work builds on prior findings that real TMS can double the odds of staying sober compared with sham, with the goal of making the brain-based treatment more precise and effective for individuals struggling with AUD.

Why it matters

Potential benefit: If successful, this approach could provide a more targeted, durable option to help people with AUD reduce relapse and maintain abstinence.

How similar studies have gone: Preliminary TMS trials in AUD showed reduced cue-reactivity and higher abstinence rates compared with sham in some participants.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Mccalley, Daniel — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Mccalley, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.